GENTAMICIN SULFATE, NEW ANTIBIOTIC AGAINST GRAM-NEGATIVE BACILLI. LABORATORY, PHARMACOLOGICAL, AND CLINICAL EVALUATION.
D000293:Adolescent; D000900:Anti-Bacterial Agents; D035843:Biomedical Research; D001769:Blood; D002648:Child; D004358:Drug Therapy; D004926:Escherichia coli; D005839:Gentamicins; D005853:Geriatrics; D006801:Humans; D007709:Klebsiella; D007759:Labyrinth Diseases; D008660:Metabolism; D008847:Micromonospora; D010600:Pharmacology; D011511:Proteus; D011549:Pseudomonas; D011704:Pyelonephritis; D012475:Salmonella; D018805:Sepsis; D012760:Shigella; D013210:Staphylococcus; D013752:Tetracycline; D014116:Toxicology; D014552:Urinary Tract Infections; D014556:Urine
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D013752:Tetracycline
ADOLESCENCE; ANTIBIOTICS; BLOOD; CHILD; CLINICAL RESEARCH; DRUG THERAPY; ESCHERICHIA COLI; GENTAMICIN; GERIATRICS; KLEBSIELLA; LABYRINTH DISEASES; METABOLISM; MICROMONOSPORA; PHARMACOLOGY; PROTEUS; PSEUDOMONAS; PYELONEPHRITIS; SALMONELLA; SEPTICEMIA; SHIGELLA; STAPHYLOCOCCUS; TETRACYCLINE; TOXICOLOGIC REPORT; URINARY TRACT INFECTIONS; URINE